Learn more

WARNER CHILCOTT CO INC

Overview
  • Total Patents
    73
About

WARNER CHILCOTT CO INC has a total of 73 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Canada, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are TRINEO BIOTECHNOLOGY CO LTD, ESTETRA SPRL and ACIEX THERAPEUTICS INC.

Patent filings per year

Chart showing WARNER CHILCOTT CO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Armstrong William Paul 16
#2 Keown James 16
#3 King John Alexander 16
#4 Mcilroy James William 15
#5 Woolfson David 14
#6 Boissonneault Roger M 13
#7 Gilligan Claire 10
#8 Mcmordie Austin 10
#9 Mckervey Anthony 8
#10 Muldoon Brendan 7

Latest patents

Publication Filing date Title
WO2008097850A1 Tretracycline compositions for topical administration
WO2008097851A1 Tetracycline compositions for topical administration
US2008113953A1 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
US2007286819A1 Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
MX2008011074A Extended cycle multiphasic oral contraceptive method.
CN101394845A Extended cycle multiphasic oral contraceptive method
CN101228177A 3-ester prodrugs of estradiol
CA2610475A1 Derivative prodrugs of ethinyl estradiol
CN101208107A Quadraphasis continuous graduated estrogen contraceptive
CA2612380A1 Estrogen compositions for vaginal administration
US2006292223A1 Gel compositions for topical administration
US2007004693A1 Estrogen compositions for vaginal administration
CN103919732A A Tetracycline Metal Complex In A Solid Dosage Form
CA2556459A1 Extended cycle multiphasic oral contraceptive method
EP1709061A1 Di-steroidal prodrugs of ethinyl estradiol
MXPA06007852A Di-steroidal prodrugs of estradiol.
EP1689411A2 Graduated estrogen contraceptive
US6962908B2 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation